Acute Phase Response & Periodontal Treatment (PERIOSYST-1)

May 30, 2015 updated by: Filippo Graziani, DDS MClinDent PhD, University of Pisa

Acute Phase Response Following Full Mouth Versus Quadrant Non-Surgical Periodontal Treatment. A Randomized Clinical Trial

This study has compared quadrant scaling and root planing (Q-SRP) versus intensive treatment performed within 24 hours (FM-SRP) in terms of acute phase responses following treatment of periodontal disease. The primary aim was to compare the differences in CRP acute increase following FM-SRP versus Q-SRP therapy (24 hours after therapy). Secondary outcomes included changes in a broad array of inflammatory and endothelial injury markers between groups. Patients were randomly assigned to either FM-SRP and Q-SRP. Data indicated that non-surgical periodontal therapy performed within 24 hours induced greater perturbations of systemic inflammation compared to conventional treatment.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Aim. A moderate acute-phase response occurs 24 hours following full-mouth non-surgical treatment (FM-SRP). Aim of this study will be to compare quadrant scaling (Q-SRP) versus FM-SRP in terms of systemic acute (24 hours) and medium-term (3 months) inflammation.

Material & Methods. 38 periodontitis-affected subjects will be randomly allocated to FM-SRP or Q-SRP after a baseline visit. Periodontal and anthropometric parameters, such as systolic and diastolic bood pressure, BMI and temperature, will be collected at baseline and 3 months. Serum samples will be drawn at baseline, 1, 7 and 90 days after treatment. High sensitivity assays for a broad array of inflammatory (PCR, IL-6, TNF-alpha) and endothelial assays will be performed.

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients presenting with probing pocket depths (PPD) ≥5 mm,
  • bleeding on probing on at least 25% of their total sites
  • documented radiographic alveolar bone loss

Exclusion Criteria:

  • age earlier than 18 and older than 70 years;
  • pregnant or lactating females;
  • females using contraceptive methods;
  • reported diagnosis of any systemic illnesses including cardiovascular, renal and liver diseases;
  • any pharmacological treatment within the 3 months before the beginning of the study;
  • PT in the previous 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Scaling & Root Planing - Quadrant
Periodontal treatment (PT), consisting in both supra- and sub-gingival mechanical instrumentation of the root surface (scaling and root planing), was performed by a single periodontist . Treatment was provided using both hand and ultrasonic instrumentation with fine tips. Local anaesthesia was used when needed and no time constraints were enforced. Q-SRP patients received four quadrants sessions of PT with an interval of 1 week between sessions
It consists in the non-surgical debridement of the sub gingival area affected by periodontal disease
Other Names:
  • SRP
Experimental: Scaling & Root Planing - Full Mouth
Periodontal treatment (PT), consisting in both supra- and sub-gingival mechanical instrumentation of the root surface (scaling and root planing), was performed by a single periodontist . Treatment was provided using both hand and ultrasonic instrumentation with fine tips. Local anaesthesia was used when needed and no time constraints were enforced. FM-SRP patients received treatment within 24 hrs in two separate sessions, one side of the mouth for each session: two quadrants were instrumented in an afternoon session, whereas the other two were instrumented the following morning
It consists in the non-surgical debridement of the sub gingival area affected by periodontal disease
Other Names:
  • SRP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
C reactive Protein
Time Frame: 24 Hours
24 Hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
C reactive Protein
Time Frame: 7 days, 90 days
7 days, 90 days
Tumor Necrosis Factor - alpha
Time Frame: 24 Hours, 7 days, 90 days
24 Hours, 7 days, 90 days
Interleukin - 6
Time Frame: 24 Hours, 7 days, 90 days
24 Hours, 7 days, 90 days
periodontal pocket depth (PPD)
Time Frame: 90 days
mean in mm
90 days
periodontal pocket depth (PPD)
Time Frame: 90 days
mean in site > 4mm
90 days
clinical attachment level (CAL)
Time Frame: 90 days
mean in mm
90 days
number of pockets > 4 mm
Time Frame: 90 days
number of pockets > 4 mm
90 days
Full Mouth Plaque Score
Time Frame: 90 days
presence/absence of dental plaque in percentual values
90 days
Full Mouth Bleeding Score
Time Frame: 90 days
presence/absence of sites bleeding on probing in percentual values
90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2012

Primary Completion (Actual)

October 1, 2013

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

May 28, 2015

First Submitted That Met QC Criteria

May 30, 2015

First Posted (Estimate)

June 3, 2015

Study Record Updates

Last Update Posted (Estimate)

June 3, 2015

Last Update Submitted That Met QC Criteria

May 30, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontal Diseases

Clinical Trials on Scaling & Root Planing

3
Subscribe